Ruby Gadelrab(@DivaBiotech) 's Twitter Profileg
Ruby Gadelrab

@DivaBiotech

CEO and Founder of @M_Disrupt, Healthcare Executive #Genomics #DigitalHealth expert, ex VP Commercial Marketing @23andme, advisor, mentor.

ID:95363183

linkhttp://www.linkedin.com/in/rubygadelrab calendar_today08-12-2009 06:00:47

20,4K Tweets

9,6K Followers

7,5K Following

Follow People
Christina Farr(@chrissyfarr) 's Twitter Profile Photo

If it makes anyone feel better to hear this, *most* founders raising money right now in health-tech are taking upwards of 100 investor meetings. In some cases, 300+.

This is a LOT of time.

VCs, you can probably be most helpful rn just not taking the meeting if you're not

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

For all PCP and Endocrinology, Clinicians - we are recruiting for a very interesting client MDisrupt - this is a paid engagement and we need as many as possible. Please sign up here if you are interested.
mdisrupt.com/join/

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Seeing a trend in companies whose business model is to sell Phentramine virtually, to patients for weight loss, for those who cant get GLPs. This feels dangerous to me since Phentramine is a very controlled substance - what do the the clinicians in my network think?

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Are there any doctors in my network still willing to prescribe Phentramine? Not asking for myself, just trying to see if this is still a thing.

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Some investors have an amazing process even if they say no, they are fast, methodical and use the appropriate diligence for the stage of company. I love giving these investors positive feedback.

Other investors processes really suck for founders, they do death by diligence,

account_circle
Harry Stebbings(@HarryStebbings) 's Twitter Profile Photo

One of the most dangerous and wrong thoughts when investing;

If a company or round isn’t hot, it can’t be a good company.

Objectively BS. Our job is to be contrarian and right, to see what others don’t and make courageous bets.

Heat does not always mean quality.

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Talking to health system and payor executives today - they are telling me they have 'Vendor fatigue' from all the digital health products that are out there and they have no simple way to evaluate what actually works and has ROI

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Where are all my womens health investors that can lead and deploy now? I saw an AWESOME company and founder that I want to share.

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Where are all my womens health investors that can lead and deploy now? I saw an AWESOME company and founder that I want to share.

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Would love your feedback if you are
- A health system exec
- A leader at a payor
- Clinician in a large group practice or health system

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Opinion: Why PHTI’s Recent Assessment of Digital Diabetes Management Tools is Inadequate medcitynews.com/2024/05/opinio…

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Over the past few days, i have been speaking to very senior executives at health systems and payers.

The number digital health area that they want to invest in is Health at Home. And they want to find the best ones quickly.

Who is building in this area?

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Would love your feedback if you are
- A health system exec
- A leader at a payor
- Clinician in a large group practice or health system

account_circle
Harry Stebbings(@HarryStebbings) 's Twitter Profile Photo

The most important trait I look for in founders I invest in:

Unwavering obsession. Beyond everything else.

This is all they can think about. This is their life's work. There is no second act.

Very rare for true obsession and dedication to not lead to real value creation.

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

If you are an executive from a healthcare system or payor or a clinician from a large group practice I would love your participation in this survey.

This survey is to help us understand how key decision makers in healthcare find, evaluate and decide which digital health

account_circle
Ruby Gadelrab(@DivaBiotech) 's Twitter Profile Photo

Yesterday an investor told me that she didn’t invest in me because I am really good at fund raising, everything comes easily to me and investors are breaking my door down to fund me.

She said her fund is for women that really need it.

I literally cried from frustration on the

account_circle